Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Loretta J. Nastoupil"'
Autor:
Heather A. Lillemoe, Roberto N. Miranda, Loretta J. Nastoupil, Mark W. Clemens, Kelly K. Hunt
Publikováno v:
Annals of Surgical Oncology. 29:5722-5729
Autor:
Heather A. Lillemoe, Roberto N. Miranda, Loretta J. Nastoupil, Mark W. Clemens, Kelly K. Hunt
Publikováno v:
Annals of Surgical Oncology. 29:5730-5731
Autor:
Jonathon B. Cohen, Daniel M Guidot, Joseph Maly, Jeffrey M. Switchenko, Loretta J. Nastoupil, Jean L. Koff, Christopher R. Flowers, Kristie A. Blum
Publikováno v:
Leukemia & Lymphoma. 59:888-895
Mantle cell lymphoma (MCL) is a heterogeneous disease with high relapse rates. Limited data guide the use of surveillance imaging following treatment. We constructed a retrospective cohort from two academic institutions of patients with MCL who compl
Autor:
Nathan Fowler, Fredrick B. Hagemeister, Chelsea C. Pinnix, Jason R. Westin, Francesco Turturro, Jennifer C. Ho, Sattva S. Neelapu, Jay Reddy, Lijuan Deng, Bouthaina S. Dabaja, Grace L. Smith, Ali Mazloom, T.Y. Andraos, Luis Fayad, Pamela K. Allen, Ken H. Young, Maria Alma Rodriguez, Loretta J. Nastoupil, Sarah A. Milgrom, Yasuhiro Oki, L. Jeffrey Medeiros, Wenli Dong
Publikováno v:
Leukemia & Lymphoma. 58:2833-2844
In 120 Stage I–IV testicular diffuse large B-cell lymphoma (DLBCL) patients treated from 1964 to 2015, we assessed the benefits of prophylactic contralateral testicular radiation (RT) and prophylactic central nervous system (CNS) therapy on overall
Autor:
Michael Wang, Nathan Fowler, Yasuhiro Oki, Francesco Turturro, Fredrick B. Hagemeister, Sattva S. Neelapu, Luis Fayad, Jason R. Westin, Jorge E. Romaguera, Hun J. Lee, Richard E. Davis, Loretta J. Nastoupil, Michelle A. Fanale, M. Alma Rodriguez, Dai Chihara, Felipe Samaniego, Bryan Do, Mohamed A. Ahmed
Publikováno v:
Cancer. 122:3145-3151
BACKGROUND The number of elderly patients with diffuse large B-cell lymphoma (DLBCL) in our aging society continues to rise, although the optimal management of very elderly patients with DLBCL is unknown. METHODS This study evaluated 207 patients who
Autor:
Hubert H. Chuang, Muzaffar H. Qazilbash, Valerie Klairisa Reed, Eric M. Rohren, Alma Rodriguez, Jatin P. Shah, L. Jeffrey Medeiros, Francesco Turturro, Grace L. Smith, Jason R. Westin, Colleen M. Costelloe, Krina K. Patel, Jorge E. Romaguera, Fredrick B. Hagemeister, Jinhai Huo, Bouthaina S. Dabaja, Chitra Hosing, Sarah A. Milgrom, Chelsea C. Pinnix, Christine F. Wogan, Sairah Ahmed, Nina Shah, Yago Nieto, Luis Fayad, Qaiser Bashir, Michelle A. Fanale, Loretta J. Nastoupil, Yasuhiro Oki
Publikováno v:
Clin Lymphoma Myeloma Leuk
Plasmablastic lymphoma is a rare, aggressive subtype of non-Hodgkin lymphoma initially described in patients infected with human immunodeficiency virus (HIV) but recently recognized in HIV-negative individuals as well. Disease most often presents as
Autor:
Mark W, Clemens, L Jeffrey, Medeiros, Charles E, Butler, Kelly K, Hunt, Michelle A, Fanale, Steven, Horwitz, Dennis D, Weisenburger, Jun, Liu, Elizabeth A, Morgan, Rashmi, Kanagal-Shamanna, Vinita, Parkash, Jing, Ning, Aliyah R, Sohani, Judith A, Ferry, Neha, Mehta-Shah, Ahmed, Dogan, Hui, Liu, Nora, Thormann, Arianna, Di Napoli, Arianna, DiNapoli, Stephen, Lade, Jorge, Piccolini, Ruben, Reyes, Travis, Williams, Colleen M, McCarthy, Summer E, Hanson, Loretta J, Nastoupil, Rakesh, Gaur, Yasuhiro, Oki, Ken H, Young, Roberto N, Miranda
Publikováno v:
Journal of Clinical Oncology. 34:160-168
Purpose Breast implant–associated anaplastic large-cell lymphoma (BI-ALCL) is a rare type of T-cell lymphoma that arises around breast implants. The optimal management of this disease has not been established. The goal of this study is to evaluate
Autor:
Keith L Dawson, Jonathan W. Friedberg, Ryan Ziemiecki, Michelle Byrtek, Brian K. Link, Christopher R. Flowers, James R. Cerhan, Rajni Sinha, Loretta J. Nastoupil, Michael Taylor, Xiaolei Zhou
Publikováno v:
British Journal of Haematology. 172:724-734
To examine the effectiveness of an initial management strategy of watchful waiting for follicular lymphoma (FL) in clinical practice, we compared outcomes for patients diagnosed 2004-2007 in the United States initially managed with watchful waiting w
Autor:
Mark W. Clemens, Kelly K. Hunt, Pei Lin, Roberto N. Miranda, Loretta J. Nastoupil, Sanam Loghavi, Sanaz Javadi, Joseph D. Khoury, L. Jeffrey Medeiros
Publikováno v:
Aesthetic Surgery Journal.
Autor:
Francesco Turturro, Maria Alma Rodriguez, Anas Younes, Sattva S. Neelapu, Lei Feng, Loretta J. Nastoupil, Yago Nieto, Michelle A. Fanale, Fredrick B. Hagemeister, Yasuhiro Oki, Luis Fayad, Bei Hu, Jorge E. Romaguera, Amanda Copeland, Felipe Samaniego, Linda Claret, Jason R. Westin, Nathan Fowler
Publikováno v:
Leukemialymphoma. 59(4)
This phase-I/phase-II study evaluated panobinostat in combination with ifosfamide, carboplatin, etoposide (P-ICE) in relapsed/refractory classical Hodgkin lymphoma. During phase I, panobinostat was given daily on Monday/Wednesday/Friday starting one